Could a common diabetes pill stop painful kidney stones?
NCT ID NCT07055282
Summary
This early-stage study is testing whether a medication called empagliflozin, usually used for diabetes and heart health, might help prevent calcium kidney stones. Researchers will give the drug to 32 adults with a history of these stones for four weeks. They will check if the medicine changes substances in the participants' urine that are known to lead to stone formation.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for KIDNEY STONES are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
University of Chicago
RECRUITINGChicago, Illinois, 60637, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.